Latest News

CMS (867.HK/8A8.SG): Innovative Drug Lumirix(R) Approved in China for Additional Indication of Atopic Dermatitis (AD)

China Medical System Holdings Limited (CMS or the Group) is pleased to announce that its subsidiary, Dermavon Holdings Limited (Dermavon, an innovative pharmaceutical company specialized...

White Gold Corp. Announces Positive Preliminary Economic Assessment with C$1.9 Billion After-Tax NPV, 38% IRR and 1.7 Year Payback Period on the White Gold...

Maiden PEA outlines a 9.4 year, 12,000 tonne per day open pit operation producing an average of 188,000 ounces of gold per year (223,000...

Popular:

11th CENTRESTAGE concludes successfully with over 12,000 buyers, setting new attendance record

- Top-tier international buyers converge as emerging markets demonstrate...

Business

Events

Marketing

Technology

Medical